Linezolid (PNU-100766)
Catalog No. A10533
Linezolid是一种用于治疗严重感染的合成抗生素。
- Viktoria Lazar, .et al. Antibiotic combinations reduce Staphylococcus aureus clearance, Nature, 2022, 610: 540-546 PMID: 36198788
- Zewen Wen, .et al. In vitro activity and adaptation strategies of eravacycline in clinical Enterococcus faecium isolates from China, J Antibiot (Tokyo), 2022, Sep;75(9):498-508 PMID: 35896611
- Meikle V, .et al. A protein complex from human milk enhances the activity of antibiotics and drugs against Mycobacterium tuberculosis, Antimicrob Agents Chemother, 2018, Nov 12. pii: AAC.01846-18 PMID: 30420480
| Catalog Num | A10533 |
|---|---|
| M. Wt | 337.3 |
| Formula | C16H20FN3O4 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 165800-03-3 |
| Synonyms | Zyvox, PNU-100766, U-100766, Zyvoxid, Zyvoxam |
| SMILES | CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F |
Linezolid是一种用于治疗严重感染的合成抗生素。
| In vitro (25°C) | DMSO | 62 mg/mL (183.78 mM) | |
| Water | Insoluble | ||
| Ethanol | 7 mg/mL (20.75 mM) | ||
| In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 28 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 29.65 mL | 148.24 mL | 296.47 mL |
| 0.5 mM | 5.93 mL | 29.65 mL | 59.29 mL |
| 1 mM | 2.96 mL | 14.82 mL | 29.65 mL |
| 5 mM | 0.59 mL | 2.96 mL | 5.93 mL |
*The above data is based on the productmolecular weight 337.3. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.